Portfolio company
Pixelgen Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
Pixelgen Technologies develops spatial proteomics kits and software for researchers in immunology, oncology and drug development to map cell surface protein architecture.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AKYA
This company provides spatial phenotyping solutions to researchers and clinicians for visualizing and quantifying protein and RNA expression in tissue sections.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
lunaphore
This company develops spatial biology platforms and automated tissue analysis systems for laboratories, hospitals and researchers to advance cancer diagnostics and drug development.
1Cell.Ai
The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
10X Genomics
This company develops instruments, consumables and software for single-cell and spatial biology research, serving academic institutions and biopharmaceutical firms.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
